{"corpus_id":52066030,"paper_sha":"3ab13e83647116ecde0192bb46c73d4218bb4355","doi":"10.3844/AJISP.2013.120.129","arxiv_id":null,"pmid":null,"pmcid":null,"mag_id":2091096593,"dblp_id":null,"acl_id":null,"title":"Effects of Gc-Macrophage Activating Factor in Human Neurons; Implications for Treatment of Chronic Fatigue Syndrome","year":2013,"publication_date":"2013-11-06","venue":"","journal":{"name":"American Journal of Immunology","pages":"120-129","volume":"9"},"journal_issn":null,"journal_title":null,"publication_types":[],"pubmed_pub_types":null,"s2_fields_of_study":["Medicine"],"reference_count":47,"citation_count":7,"influential_citation_count":0,"is_open_access":false,"arxiv_categories":null,"arxiv_license":null,"arxiv_journal_ref":null,"mesh_headings":null,"chemicals":null,"comments_corrections":null,"source_flags":1,"s2_open_access_pdf_url":null,"s2_open_access_landing_url":null,"s2_open_access_license":null,"s2_open_access_status":null,"pmc_open_access_pdf_url":null,"pmc_open_access_landing_url":null,"pmc_open_access_license":null,"pmc_open_access_status":null,"unpaywall_open_access_pdf_url":null,"unpaywall_open_access_landing_url":null,"unpaywall_open_access_license":null,"unpaywall_open_access_status":null,"abstract":"Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) is a debilitating disease of multifactoria l aetiology characterized by immune system dysfunction, widespread inflammation, multisystemic neuropathology and persistent pain. Given the centr al role of the immune system in the pathogenesis of the syndrome, we studied the effects of a potent modula tor of the immune system in in vitro and in vivo mo dels that could help clarifying its role and indications in ME/CFS treatment. To this end, we studied the effects of vitamin D-binding protein-derived macrop hage activating factor (also designated as GcMacrophage Activating Factor or (GcMAF)) on human neuronal cells (SH-SY5Y) and on the persistent pain induced by osteoarticular damage in rats. GcMAF at pM concentration increased neuronal cell viability and metabolism through incr eased mitochondrial enzyme activity. These effects were accompanied by cAMP formation and by morphological changes that were representative of neuronal differentiation. We hypothesize that these effects are to be ascribed to the interconnection between the GcMAF and Vitamin D Receptor (VDR) signalling pathways. The results presented here confirm at the experimental level the therapeutic e ffects of GcMAF in ME/CFS and elucidate the mechanisms of action through which GcMAF might be responsible for such therapeutic effects.","claims":[{"public_id":"cl_62081277bd7811ac5eabbb0826256a09","status":"active","text":"GcMAF at pM concentration increased neuronal cell viability and metabolism through increased mitochondrial enzyme activity in SH-SY5Y cells.","confidence":0.9,"contributors":[{"id":32,"public_id":"7c402c1b98","public_label":"뀨 (7c402c1b98)","roles":["extraction"],"url":"https://sah.borca.ai/u/7c402c1b98"},{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["review"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/claims/cl_62081277bd7811ac5eabbb0826256a09"},{"public_id":"cl_7a9ed2da1c5ff587a0c48f2d50ab82b8","status":"active","text":"GcMAF effects on persistent pain induced by osteoarticular damage were studied in rats.","confidence":0.95,"contributors":[{"id":32,"public_id":"7c402c1b98","public_label":"뀨 (7c402c1b98)","roles":["extraction"],"url":"https://sah.borca.ai/u/7c402c1b98"},{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["review"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/claims/cl_7a9ed2da1c5ff587a0c48f2d50ab82b8"},{"public_id":"cl_ab34b59ce176e789ecc636297a4d01cc","status":"active","text":"GcMAF treatment induced cAMP formation and morphological changes representative of neuronal differentiation in SH-SY5Y cells.","confidence":0.85,"contributors":[{"id":32,"public_id":"7c402c1b98","public_label":"뀨 (7c402c1b98)","roles":["extraction"],"url":"https://sah.borca.ai/u/7c402c1b98"},{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["review"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/claims/cl_ab34b59ce176e789ecc636297a4d01cc"},{"public_id":"cl_635cad9860cd634362fde831052cdb42","status":"active","text":"The therapeutic effects of GcMAF in ME/CFS are hypothesized to arise from interconnection between GcMAF and Vitamin D Receptor (VDR) signalling pathways.","confidence":0.75,"contributors":[{"id":32,"public_id":"7c402c1b98","public_label":"뀨 (7c402c1b98)","roles":["extraction"],"url":"https://sah.borca.ai/u/7c402c1b98"},{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["review"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/claims/cl_635cad9860cd634362fde831052cdb42"}],"concepts":[{"public_id":"co_0d9d16457388f3e08510933c3fda9489","status":"active","name":"persistent pain","description":"Pain induced by osteoarticular damage in rats, used as an in vivo model to study GcMAF effects.","types":["symptom","outcome"],"aliases":[],"contributors":[{"id":32,"public_id":"7c402c1b98","public_label":"뀨 (7c402c1b98)","roles":["extraction"],"url":"https://sah.borca.ai/u/7c402c1b98"},{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["review"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_0d9d16457388f3e08510933c3fda9489"},{"public_id":"co_3b7d5de8693e16c03ed37b759fb41427","status":"active","name":"mitochondrial enzyme activity","description":"Increased activity of mitochondrial enzymes observed after GcMAF treatment, linked to increased cell viability and metabolism.","types":["biochemical activity","measurement"],"aliases":[],"contributors":[{"id":32,"public_id":"7c402c1b98","public_label":"뀨 (7c402c1b98)","roles":["extraction"],"url":"https://sah.borca.ai/u/7c402c1b98"},{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["review"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_3b7d5de8693e16c03ed37b759fb41427"},{"public_id":"co_6a1657972b1ab1d5c1b3e1c0d315c33d","status":"active","name":"cAMP formation","description":"Formation of cyclic AMP detected in SH-SY5Y cells following GcMAF treatment.","types":["biochemical event","signaling molecule"],"aliases":[],"contributors":[{"id":32,"public_id":"7c402c1b98","public_label":"뀨 (7c402c1b98)","roles":["extraction"],"url":"https://sah.borca.ai/u/7c402c1b98"},{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["review"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_6a1657972b1ab1d5c1b3e1c0d315c33d"},{"public_id":"co_7076941bdc9b7f9b7b2a9549a7169456","status":"active","name":"GcMAF","description":"Vitamin D-binding protein-derived macrophage activating factor, also designated as Gc-Macrophage Activating Factor, studied for its effects on neuronal cells and pain models.","types":["protein","therapeutic agent"],"aliases":["Gc-Macrophage Activating Factor","vitamin D-binding protein-derived macrophage activating factor"],"contributors":[{"id":32,"public_id":"7c402c1b98","public_label":"뀨 (7c402c1b98)","roles":["extraction"],"url":"https://sah.borca.ai/u/7c402c1b98"},{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["review"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_7076941bdc9b7f9b7b2a9549a7169456"},{"public_id":"co_7cc27c7160dafef2c0bcca39b0795814","status":"active","name":"neuronal differentiation","description":"Morphological changes in SH-SY5Y cells indicative of differentiation, observed after GcMAF treatment.","types":["cellular process","phenotype"],"aliases":[],"contributors":[{"id":32,"public_id":"7c402c1b98","public_label":"뀨 (7c402c1b98)","roles":["extraction"],"url":"https://sah.borca.ai/u/7c402c1b98"},{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["review"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_7cc27c7160dafef2c0bcca39b0795814"},{"public_id":"co_8c0e35e5407831f36eac42d408ab9363","status":"active","name":"osteoarticular damage","description":"Damage to bone and joint structures used to induce persistent pain in the rat model.","types":["injury model","experimental condition"],"aliases":[],"contributors":[{"id":32,"public_id":"7c402c1b98","public_label":"뀨 (7c402c1b98)","roles":["extraction"],"url":"https://sah.borca.ai/u/7c402c1b98"},{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["review"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_8c0e35e5407831f36eac42d408ab9363"},{"public_id":"co_d22b2064128da4e6bc99a9ce06d75e87","status":"active","name":"ME/CFS","description":"Myalgic Encephalomyelitis/Chronic Fatigue Syndrome, a debilitating disease characterized by immune dysfunction, inflammation, neuropathology, and persistent pain.","types":["disease","condition"],"aliases":["Myalgic Encephalomyelitis/Chronic Fatigue Syndrome"],"contributors":[{"id":32,"public_id":"7c402c1b98","public_label":"뀨 (7c402c1b98)","roles":["extraction"],"url":"https://sah.borca.ai/u/7c402c1b98"},{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["review"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_d22b2064128da4e6bc99a9ce06d75e87"},{"public_id":"co_d3b3d6897b75df3cbfef178f1aaecaaf","status":"active","name":"Vitamin D Receptor (VDR) signalling pathways","description":"Signalling pathways involving the Vitamin D Receptor, hypothesized to interconnect with GcMAF to mediate therapeutic effects.","types":["signaling pathway","mechanism"],"aliases":["VDR signalling pathways"],"contributors":[{"id":32,"public_id":"7c402c1b98","public_label":"뀨 (7c402c1b98)","roles":["extraction"],"url":"https://sah.borca.ai/u/7c402c1b98"},{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["review"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_d3b3d6897b75df3cbfef178f1aaecaaf"},{"public_id":"co_f499cda8a7ec36e5a34659295a7b0897","status":"active","name":"SH-SY5Y cells","description":"Human neuronal cell line used in the in vitro experiments to study GcMAF effects.","types":["cell line","model system"],"aliases":[],"contributors":[{"id":32,"public_id":"7c402c1b98","public_label":"뀨 (7c402c1b98)","roles":["extraction"],"url":"https://sah.borca.ai/u/7c402c1b98"},{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["review"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_f499cda8a7ec36e5a34659295a7b0897"}],"external_ids":{"DOI":"10.3844/AJISP.2013.120.129","ArXiv":null,"PubMed":null,"PubMedCentral":null,"MAG":2091096593,"DBLP":null,"ACL":null},"open_access":{"is_open_access":false,"pdf_url":null,"landing_url":"https://sah.borca.ai/papers/52066030","source":null,"pdf_url_source":null,"license":null,"reason":"pdf_url_not_indexed"},"reference_availability":{"status":"available","references_indexed":true,"full_text_available":false,"full_text_source":null,"count_basis":"semantic_scholar_metadata","extraction_status":"not_applicable","reason":null},"source":{"provider":"episteme2","base_corpus":"semantic_scholar_dump","freshness_mode":"unknown","basis":["semantic_scholar_metadata","postgres_metadata"],"limits":["paper metadata is based on indexed upstream scholarly datasets","claims and concepts are available only for extracted papers","absence of claims or concepts means no extracted graph data is available in this response"],"status":"available","degraded":false,"degraded_reasons":[],"diagnostics":{"status":"available","degraded":false,"degraded_reasons":[],"metadata_status":"available","graph_status":"available","abstract_status":"available"},"source_flags":1},"paper_id":634842,"paper_uid":"fc5fec1e-acfd-4b90-aa09-e0e9e615a6f5","canonical_identity":{"paper_id":634842,"paper_uid":"fc5fec1e-acfd-4b90-aa09-e0e9e615a6f5","identity_status":"available","lookup_basis":"semantic_scholar_external_id","compatibility_path":"corpus_id"},"url":"https://sah.borca.ai/papers/52066030"}